Mueller, S.K.; Haderlein, M.; Lettmaier, S.; Agaimy, A.; Haller, F.; Hecht, M.; Fietkau, R.; Iro, H.; Mantsopoulos, K.
Targeted Therapy, Chemotherapy, Immunotherapy and Novel Treatment Options for Different Subtypes of Salivary Gland Cancer. J. Clin. Med. 2022, 11, 720.
https://doi.org/10.3390/jcm11030720
AMA Style
Mueller SK, Haderlein M, Lettmaier S, Agaimy A, Haller F, Hecht M, Fietkau R, Iro H, Mantsopoulos K.
Targeted Therapy, Chemotherapy, Immunotherapy and Novel Treatment Options for Different Subtypes of Salivary Gland Cancer. Journal of Clinical Medicine. 2022; 11(3):720.
https://doi.org/10.3390/jcm11030720
Chicago/Turabian Style
Mueller, Sarina K., Marlen Haderlein, Sebastian Lettmaier, Abbas Agaimy, Florian Haller, Markus Hecht, Rainer Fietkau, Heinrich Iro, and Konstantinos Mantsopoulos.
2022. "Targeted Therapy, Chemotherapy, Immunotherapy and Novel Treatment Options for Different Subtypes of Salivary Gland Cancer" Journal of Clinical Medicine 11, no. 3: 720.
https://doi.org/10.3390/jcm11030720
APA Style
Mueller, S. K., Haderlein, M., Lettmaier, S., Agaimy, A., Haller, F., Hecht, M., Fietkau, R., Iro, H., & Mantsopoulos, K.
(2022). Targeted Therapy, Chemotherapy, Immunotherapy and Novel Treatment Options for Different Subtypes of Salivary Gland Cancer. Journal of Clinical Medicine, 11(3), 720.
https://doi.org/10.3390/jcm11030720